tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:POLB Stock Latest News

Poolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
Company AnnouncementsPoolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
5d ago
Poolbeg Pharma Increases Share Capital After Option Exercises
PremiumCompany Announcements
Poolbeg Pharma Increases Share Capital After Option Exercises
6d ago
Poolbeg Pharma Anticipates Clinical Breakthroughs Following a Year of Progress in 2025
PremiumCompany Announcements
Poolbeg Pharma Anticipates Clinical Breakthroughs Following a Year of Progress in 2025
2M ago
Poolbeg Pharma Leads in Groundbreaking Cancer Immunotherapy Research
PremiumCompany Announcements
Poolbeg Pharma Leads in Groundbreaking Cancer Immunotherapy Research
2M ago
Poolbeg Pharma Secures European Patent for POLB 001
PremiumCompany Announcements
Poolbeg Pharma Secures European Patent for POLB 001
2M ago
Poolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials
PremiumCompany AnnouncementsPoolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials
4M ago
Poolbeg Pharma Advances POLB 001 Trial with Key Partnership and Drug Supply
Premium
Company Announcements
Poolbeg Pharma Advances POLB 001 Trial with Key Partnership and Drug Supply
4M ago
Poolbeg Pharma Announces Change in Voting Rights Structure
Premium
Company Announcements
Poolbeg Pharma Announces Change in Voting Rights Structure
7M ago
Roaring Waters Capital Acquires 5.74% Stake in Poolbeg Pharma
PremiumCompany Announcements
Roaring Waters Capital Acquires 5.74% Stake in Poolbeg Pharma
7M ago
Poolbeg Pharma’s Executive Chair Increases Stake in Fundraising Effort
PremiumCompany Announcements
Poolbeg Pharma’s Executive Chair Increases Stake in Fundraising Effort
7M ago
Poolbeg Pharma Secures Shareholder Approval and Expands Capital
PremiumCompany Announcements
Poolbeg Pharma Secures Shareholder Approval and Expands Capital
7M ago
Poolbeg Pharma’s POLB 001 Receives FDA Orphan Drug Designation
PremiumCompany Announcements
Poolbeg Pharma’s POLB 001 Receives FDA Orphan Drug Designation
8M ago
Poolbeg Pharma Releases Annual Report and Announces Fundraising Initiative
PremiumCompany AnnouncementsPoolbeg Pharma Releases Annual Report and Announces Fundraising Initiative
8M ago
Poolbeg Pharma Raises £4.865 Million to Advance Clinical Trials
Premium
Company Announcements
Poolbeg Pharma Raises £4.865 Million to Advance Clinical Trials
9M ago
Poolbeg Pharma Expands BookBuild Offer Amid Strong Demand
Premium
Company Announcements
Poolbeg Pharma Expands BookBuild Offer Amid Strong Demand
9M ago
Poolbeg Pharma Raises £4.715 Million to Advance Clinical Trials
PremiumCompany Announcements
Poolbeg Pharma Raises £4.715 Million to Advance Clinical Trials
9M ago
Poolbeg Pharma Announces £4.1 Million Fundraising to Advance Clinical Trials
PremiumCompany Announcements
Poolbeg Pharma Announces £4.1 Million Fundraising to Advance Clinical Trials
9M ago
Poolbeg Pharma Launches £100,000 Retail Offer to Advance Key Trials
PremiumCompany Announcements
Poolbeg Pharma Launches £100,000 Retail Offer to Advance Key Trials
9M ago
Poolbeg Pharma Reports 2024 Results, Highlights Key Pipeline Advancements
PremiumCompany Announcements
Poolbeg Pharma Reports 2024 Results, Highlights Key Pipeline Advancements
9M ago
Poolbeg Pharma to Showcase Innovations at Key Industry Conferences
PremiumCompany AnnouncementsPoolbeg Pharma to Showcase Innovations at Key Industry Conferences
10M ago
Poolbeg Pharma Strengthens Global IP Portfolio with Korean Patent Grant
Premium
Company Announcements
Poolbeg Pharma Strengthens Global IP Portfolio with Korean Patent Grant
11M ago
Poolbeg Pharma Sees Shift in Major Holdings
Premium
Company Announcements
Poolbeg Pharma Sees Shift in Major Holdings
12M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >